Fifth Third Bancorp
MNTA

Fifth Third Bancorp’s Momenta Pharmaceuticals, Inc. MNTA Stock Holding History

Fifth Third Bancorp’s Portfolio MNTA Stock Details MNTA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q4 		– Sell
-50
Closed -$3K – 2507
2020
Q3 		$3K Buy
+50
New +$2.07K ﹤0.01% 2007
2016
Q1 		– Sell
-175
Closed -$3K – 2776
2015
Q4 		$3K Buy
175
+2
+1% +$33 ﹤0.01% 2407
2015
Q3 		$3K Buy
173
+66
+62% +$1.35K ﹤0.01% 2540
2015
Q2 		$2K Buy
107
+21
+24% +$418 ﹤0.01% 2635
2015
Q1 		$1K Buy
+86
New +$1.12K ﹤0.01% 2706

Fifth Third Bancorp's MNTA Position: Q4 2020 in Review

Fifth Third Bancorp sold out of Momenta Pharmaceuticals, Inc. (MNTA) in Q4 2020, closing a stake of 50 shares — an estimated $3K sold.

Fifth Third Bancorp first reported a position in MNTA in Q1 2015 and held it in 5 quarters. The position peaked at $3K in Q3 2020. 0 funds tracked by Wall St. Rank hold MNTA as of Q4 2020.

  • Fifth Third Bancorp reported no remaining Momenta Pharmaceuticals, Inc. position as of Q4 2020 after selling out during the quarter.
  • Fifth Third Bancorp sold 50 Momenta Pharmaceuticals, Inc. shares in Q4 2020, an estimated $3K.
  • Fifth Third Bancorp first reported a position in Momenta Pharmaceuticals, Inc. in Q1 2015 and held it in 5 quarters.
  • Fifth Third Bancorp's Momenta Pharmaceuticals, Inc. position peaked at $3K in Q3 2020.
  • 0 funds tracked by Wall St. Rank held Momenta Pharmaceuticals, Inc. as of Q4 2020.

Based on Fifth Third Bancorp's 13F filing for Q4 2020, filed 16 Feb 2021.